Key products
in other areas

Sativex® is a cannabis-based medicine containing tetrahydrocannabinol (THC) and cannabidiol (CBD) which is indicated as a treatment for the improvement of symptoms in adult patients with moderate or severe spasticity due to multiple sclerosis (MS) who have not adequately responded to other antispastic medications and who have shown a clinically significant improvement in symptoms related to spasticity during an initial trial treatment period.

Both products are indicated to help control high blood cholesterol, LDL cholesterol, and triglyceride levels, often associated with low HDL cholesterol. Containing rosuvastatin, a statin medication that works by reducing the amount of cholesterol produced by the liver, Crestor® and Provisacor® (rosuvastatin) are indicated for the prevention of heart attacks or strokes in patients considered at high risk of experiencing a first cardiovascular event.

Almax® is an effective treatment for heartburn and gastric acidity in adults and children over 12 years old. Formulated with almagate, it works by neutralizing stomach acid to provide fast and reliable symptom relief – addressing a condition that affects over 40% of the population.

Marketed in over 30 countries worldwide, the ebastine family of antihistamines (Ebastel®, Kestin®, Kestine®, Evastel®, Estivan®) is a once-daily, non-sedating, selective, and long-acting treatment for allergic rhinitis (seasonal and perennial), chronic idiopathic urticaria, allergic dermatitis and allergy-related conjunctivitis. Benefits of this second-generation H1 receptor antagonist include good symptom relief, a positive safety and tolerability profile, lack of drowsiness, and all-day coverage.

These treatments are indicated as a supplement to diet and exercise to improve glycaemic control in patients with Type 2 Diabetes Melitus inadequately controlled on metformin alone or those already being treated with the combination of sitagliptin and metformin. Both medicines are also indicated for use as part of a triple therapy regimen alongside sulphonylurea to complement diet and exercise for patients who are inadequately controlled on the maximum tolerated dose of metformin and a sulphonylurea.
Tesavel (sitagliptin) is also indicated as adjunctive therapy to insulin (i.e., triple combination therapy) in addition to diet and exercise, to improve glycemic control in patients for whom a stable dose of insulin and metformin alone does not provide adequate glycemic control.

Prometax® is a daily transdermal medicated patch used to alleviate Alzheimer's-related dementia symptoms. This medication helps to improve patients´ daily lives without needing regular medication. It is highly beneficial for individuals who have difficulty swallowing oral medication. Acquired in 2023, Prometax® (rivastigmine patches) is marketed in Spain, where Alzheimer's is the most common form of dementia, affecting over 800,000 people – a number expected to rise with the aging population.

Physiorelax ® is a brand of topical products of natural origin indicated for muscle health. The main ingredient is Helenalin2, which combines arnica, hypericum, harpagophytum, and calendula essential oils.
The brand portfolio now includes a variety of products like Forte Plus, Heat and Cold effects, and a CBD-based cream, catering to diverse user needs. Acquired by Almirall in 2023, it is marketed in Spain.